To read the full story, subscribe or sign in.

Financings for June 2, 2026

June 2, 2026

Biopharma and med-tech companies in Asia-Pacific raising money in public or private financings: Hanchorbio, Longbio.

BioWorld Asia Briefs Financings

Today's news in brief

BioWorld

BioWorld briefs for June 1, 2026.

TROP2 ADCs progress into first-line for lung, breast cancers

BioWorld

Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...

Healthy (left) vs. cancerous bone marrow

BMS’ mezigdomide doubles PFS in multiple myeloma

BioWorld

Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...

Liver with hepatitis viruses, blood cells

Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections

BioWorld

GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...

ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal

BioWorld

Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...